In the Aftermath of Albrecht: Implications of the Supreme Court’s Ruling on Preemption for Pharmaceutical Products Liability Litigation

Venable partner Steve Marshall will address the 24th Annual Conference on Drug and Medical Device Litigation in New York City on December 10-11.

The panel will discuss the implications of the Supreme Court's ruling on life sciences products liability litigation. Topics will include:

• Aspects of Albrecht that will likely be the subject of future litigation
• Potential application of Albrecht to future factual disputes encountered in the context of implied preemption, and an express preemption discussion of the most important case law developments of the past year and their real-life impact on drug and medical device litigation
• Possible jurisprudential implications of the Supreme Court's ruling